These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12183652)

  • 41. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
    Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
    Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females.
    Qiu J; Xue C; Bosch MA; Murphy JG; Fan W; Rønnekleiv OK; Kelly MJ
    Mol Pharmacol; 2007 Oct; 72(4):885-96. PubMed ID: 17622577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus.
    Fenik P; Veasey SC
    Am J Respir Crit Care Med; 2003 Feb; 167(4):563-9. PubMed ID: 12406845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
    Newman-Tancredi A; Cussac D; Marini L; Millan MJ
    Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line SH-SY5Y.
    Briddon SJ; Leslie RA; Elliott JM
    Br J Pharmacol; 1998 Oct; 125(4):727-34. PubMed ID: 9831908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.
    Herrick-Davis K; Grinde E; Weaver BA
    Eur J Pharmacol; 2007 Jul; 568(1-3):45-53. PubMed ID: 17507008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligands.
    Zhang JY; Kowal DM; Nawoschik SP; Dunlop J; Pausch MH; Peri R
    Assay Drug Dev Technol; 2010 Feb; 8(1):106-13. PubMed ID: 19922239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-HT(2) receptor-mediated phosphoinositide hydrolysis in bovine ciliary epithelium.
    Inoue-Matsuhisa E; Moroi SE; Takenaka H; Sogo S; Mano T
    J Ocul Pharmacol Ther; 2003 Feb; 19(1):55-62. PubMed ID: 12648304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of serotonin 5-HT2C receptors by chronic ligand exposure.
    Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A
    Eur J Pharmacol; 2004 Sep; 498(1-3):59-69. PubMed ID: 15363976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
    Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
    Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
    Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
    Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
    Berg KA; Dunlop J; Sanchez T; Silva M; Clarke WP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1084-92. PubMed ID: 18065501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI).
    Qu Y; Chang L; Klaff J; Balbo A; Rapoport SI
    Neuropsychopharmacology; 2003 Feb; 28(2):244-52. PubMed ID: 12589377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A unique phenotype of 5-HT2C, agonist-induced GTPgamma35S binding, transferable to 5-HT2A and 5-HT2B, upon swapping intracellular regions.
    Alberts GL; Chio CL; Im WB; Slightom JL
    Br J Pharmacol; 2003 Feb; 138(3):427-34. PubMed ID: 12569067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of different serotonin receptor subtypes on growth hormone secretion.
    Valverde I; Penalva A; Dieguez C
    Neuroendocrinology; 2000 Feb; 71(2):145-53. PubMed ID: 10686528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
    Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
    Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice.
    Basselin M; Fox MA; Chang L; Bell JM; Greenstein D; Chen M; Murphy DL; Rapoport SI
    Neuropsychopharmacology; 2009 Jun; 34(7):1695-709. PubMed ID: 19145225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.